Evaluation of the concentration of malondialdehyde and nitrite in patients with sickle cell anemia treated or not with hydroxyurea

被引:0
|
作者
Dias Elias, Darcielle Bruna [1 ]
de Freitas, Rivelilson Mendes [2 ]
Goncalves, Romelia Pinheiro [3 ]
Ferreira Magalhaes, Hemerson Yuri [4 ]
de Sousa, Jacqueline Holanda [5 ]
Meira Magalhaes, Silvia Maria
机构
[1] Univ Fed Ceara UFC, Dev & Technol Innovat Drugs, Fortaleza, CE, Brazil
[2] Univ Fed Piaui UFPI, Teresina, PI, Brazil
[3] Univ Fed Ceara, Dept Univ Fed Ceara, Clin Analyses & Toxicol, Fortaleza, CE, Brazil
[4] Univ Fed Ceara, Hosp Univ Walter Cantideo, Fortaleza, CE, Brazil
[5] Univ Fed Ceara, Hosp Univ Walter Cantideo, Fortaleza, CE, Brazil
来源
EINSTEIN-SAO PAULO | 2010年 / 8卷 / 04期
关键词
Anemia; sickle cell/drug therapy; Malondialdehyde; Thiobarbituric acid reactive substances; Nitrite; Oxidative stress; Hydroxyurea/therapeutic use;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the serum levels of malondialdehyde and nitrite in patients with sickle cell anemia treated or not with hydroxyurea in outpatient's setting. Methods: Of the 65 patients with sickle cell anemia selected for the study, 51 were not treated with hydroxyurea (Group 1), 14 made chronic use of hydroxyurea (Group 2) and 20 individuals had no hemoglobinopathies (Control Group). Results: The Control Group had a lower and more homogeneous concentration of malondialdehyde levels as compared to the other groups. The results of Groups 1 and 2 showed increased values of malondialdehyde levels when compared to the Control Group. Considering the values of Groups 1 and 2, there were no significant changes in the malondialdehyde levels. There was no significant difference in the serum levels of nitrite between the groups. Group 2 presented a statistically significant correlation between serum malondialdehyde levels and the clinical variables investigated. In turn, Group 1 showed correlation only with occurrence of three or more vaso-occlusive crises. There was no correlation between nitrite levels and the clinical variables. Conclusion: The results revealed that during the pathogenesis of sickle cell anemia, an increase in lipid peroxidation was observed. On the other hand, no changes in oxidative parameters were detected during treatment with hydroxyurea, probably due to the short period of treatment of the patients studied.
引用
收藏
页码:414 / 418
页数:5
相关论文
共 50 条
  • [1] Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea
    Reno, Cristiane O.
    Barbosa, Amanda Rodrigues
    de Carvalho, Sara Santos
    Pinheiro, Melina B.
    Rios, Danyelle Romana
    Cortes, Vanessa F.
    Barbosa, Leandro A.
    Santos, Herica L.
    ANNALS OF HEMATOLOGY, 2020, 99 (05) : 937 - 945
  • [2] Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea
    Cristiane O. Renó
    Amanda Rodrigues Barbosa
    Sara Santos de Carvalho
    Melina B. Pinheiro
    Danyelle Romana Rios
    Vanessa F. Cortes
    Leandro A. Barbosa
    Hérica L. Santos
    Annals of Hematology, 2020, 99 : 937 - 945
  • [3] Hydroxyurea for sickle cell anemia
    Bachmeyer, Claude
    Aractingi, Selim
    Lionnet, Francois
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01): : 98 - 98
  • [4] Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
    Rodriguez Jorge, Belkis Lazara
    Morejon Diaz, Lucia
    Leon Rayas, Yoandra
    Santa Cruz, Maria
    FINLAY, 2021, 11 (01): : 66 - 73
  • [5] Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea
    Santos, Brigida
    Ginete, Catarina
    Goncalves, Elisangela
    Delgadinho, Mariana
    Miranda, Armandina
    Faustino, Paula
    Arez, Ana Paula
    Brito, Miguel
    BLOOD CELLS MOLECULES AND DISEASES, 2024, 105
  • [6] Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea
    Wilson, S
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (11) : 925 - 926
  • [7] Growth and Puberty in African Children with Sickle Cell Anemia Treated with Hydroxyurea
    Backeljauw, Philippe
    Tomlinson, George A.
    Smart, Luke R.
    Tshilolo, Leon
    Williams, Thomas N.
    Santos, Brigida
    Olupot-Olupot, Peter
    Stuber, Susan E.
    Lane, Adam C.
    Latham, Teresa S.
    Ware, Russell E.
    BLOOD, 2024, 144 : 544 - 545
  • [8] STIMULATION OF F-CELL PRODUCTION IN PATIENTS WITH SICKLE-CELL-ANEMIA TREATED WITH CYTARABINE OR HYDROXYUREA
    VEITH, R
    GALANELLO, R
    PAPAYANNOPOULOU, T
    STAMATOYANNOPOULOS, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25): : 1571 - 1575
  • [10] Hydroxyurea for the treatment of sickle cell anemia
    Platt, Orah S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13): : 1362 - 1369